Med. praxi. 2023;20(3):185-186 | DOI: 10.36290/med.2023.029

Ambulantní monitorace krevního tlaku

MUDr. Jan Hůlka
ProKardio HK, s. r. o., Hradec Králové

Accepted: June 9, 2023; Published: June 15, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hůlka J. Ambulantní monitorace krevního tlaku. Med. praxi. 2023;20(3):185-186. doi: 10.36290/med.2023.029.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Widimský J, Filipovský J, Ceral J, et al. Diagnostické a léčebné postupy u arteriální hypertenze. Česká společnost pro hypertenzi. [Internet]. 2022. Available from: https://www.hypertension.cz/doporuceni­‑a­‑prakticke­‑postupy­‑csh.
    2. Cífková R, Bruthans J, Wohlfahrt P, et al. 30-year trends in major cardiovascular risk factors in the Czech population, Czech MONICA and Czech post­‑MONICA. 1985-2016/17. PLoS One. 2020;15:e0232845. Go to original source... Go to PubMed...
    3. Mancia G, Bombelli M, Facchetti R, et al. Increased long­‑term risk of new­‑onset diabetes mellitus in white­‑coat and masked hypertension. J Hypertens. 2009;27:1672-8. Go to original source... Go to PubMed...
    4. Fagard RH, Cornelissen VA. Incidence of cardiovascular events in white­‑coat, masked and sustained hypertension versus true normotension: a meta­‑analysis. J Hypertens. 2007;25:2193-8. Go to original source... Go to PubMed...
    5. Hodsman GP, Isles CG, Murray GD, et al. Factors related to first dose hypotensive effect of captopril: prediction and treatment. Br Med J (Clin Res Ed). 1983;286:832-4. Go to original source... Go to PubMed...

    Return to the content


    Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.